New Jersey A538 mandates the licensure of pharmaceutical representatives, establishing standards and requirements for their practice.
New Jersey A538, the "Pharmaceutical Representative Licensing Act," requires the licensure of individuals marketing pharmaceuticals to practitioners. The State Board of Medical Examiners will oversee this process, including setting education and experience criteria, reviewing applicants, and issuing licenses. Licensed representatives must complete continuing education, including ethics and pharmacology training, every two years. The board can suspend or revoke licenses for unprofessional conduct.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.